Since its founding in 1971, Genepharm has been consistently developing reliable generic pharmaceutical products that are affordable for all. It is a pharmaceutical company that continuously invests in infrastructure and technology, providing high-quality products with a focus on people.

At its state-of-the-art, privately owned facilities in Pallini, Attica—spanning a total area of 12,000 sq.m.—Genepharm operates two separate, advanced production lines, designed in full compliance with European standards (EU GMPs). Each line specializes in two categories of medicines: conventional and oncology solid forms.

Genepharm’s branded products are available in over 90 countries, addressing the healthcare needs of people worldwide. Its export activity is continuously expanding, always aiming to meet the needs of patients around the globe. The company possesses strong expertise in both conventional and technologically advanced forms of pharmaceuticals.